Mechanistic insights into IL-6-mediated NK cell dysfunction in NSCLC via the IRE1α-XBP1s-STAT3-UBE2S axis

Yazhen Wang1, Zichan Guo2, Anqi Xu1,3

  • 1Department of Immunology, Fourth Military Medical University, Xi'an, Shaanxi, China.

NPJ Precision Oncology
|November 18, 2025
PubMed

Insights

Natural killer (NK) cell immunotherapy is less effective in non-small cell lung cancer (NSCLC) because tumors suppress NK cells. This study reveals a mechanism involving XBP1s, IL-6, and UBE2S that reduces NKp30, impairing NK cell function in NSCLC.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Natural killer (NK) cell immunotherapy shows limited success in non-small cell lung cancer (NSCLC) due to the tumor immune microenvironment.
  • Interleukin-6 (IL-6) is implicated in NK cell dysfunction and reduced NKp30 expression, but the precise mechanisms are unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying NK cell dysfunction in NSCLC.
  • To identify key regulators of NKp30 expression and function in the context of NSCLC.

Main Methods:

  • Correlation analysis of IL-6 and NKp30 expression with NK cell function and prognosis in NSCLC patients.
  • In vitro studies to elucidate the regulatory pathways of IL-6 and NKp30.
  • Analysis of the IRE1α-XBP1s signaling pathway and its role in IL-6 transcription.
  • Investigation of IL-6-induced STAT3-dependent UBE2S upregulation and its effect on NKp30 degradation.

Main Results:

  • Elevated IL-6 and reduced NKp30 expression were observed in NSCLC patients, correlating with poor prognosis and NK cell dysfunction.
  • Tumoral IL-6 was found to inversely regulate NKp30 expression both clinically and in vitro.
  • The IRE1α-XBP1s pathway was identified as a key activator of IL-6 transcription.
  • IL-6 was shown to induce STAT3-dependent UBE2S upregulation, leading to NKp30 degradation in NK cells.
  • A novel XBP1s/IL-6/STAT3-UBE2S axis was established, driving NKp30 loss and NK cell functional impairment.

Conclusions:

  • Tumor-intrinsic mechanisms involving the XBP1s/IL-6/STAT3-UBE2S axis contribute to NK cell suppression in NSCLC.
  • Targeting XBP1s, IL-6, or UBE2S may represent a viable strategy to enhance NK cell-based immunotherapies for NSCLC.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.8K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
7.8K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.6K